A Randomized, Open-Label, Phase 3 Trial of NOV-002 in Combination with Paclitaxel and Carboplatin Alone for the Treatment of Advanced Non-small Cell Lung Cancer...
|Effective start/end date||1/19/07 → 10/31/10|
- ICON CLINICAL RESEARCH, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.